medical progress

Research, Industry, Academic and Patient Groups Join Forces for Week of Advocacy to Save Research, November 12-16, 2012 WASHINGTON ’€“ November 1, 2012 ’€“ Research!America, along with several dozen patient, industry, academic and health organizations, has coordinated a Week of Advocacy to Save Research for the week of November 12-16, 2012. The unified campaign is intended to convince policy makers to champion medical innovation, rather than undercut it, as decisions are made to address the ’€œfiscal cliff.’€ The campaign ’€” We Need Cures, Not Cuts ’€”is designed to raise awareness about the importance of making biomedical and health research a higher national priority. The campaign will...
Dear Research Advocate, This week’€™s Nobel Prize announcements are a fine reminder of how government-supported research plays a critical role in expanding our knowledge, leading not only to worldwide recognition but taking us closer to understanding and curing disease. The winners of the prize for chemistry, Dr. Robert Lefkowitz, Howard Hughes Medical Research investigator and professor at Duke University Medical Center, and Dr. Brian Kobilka of Stanford University School of Medicine both received grants from the National Institutes of Health, as did one of the physiology and medicine awardees, Dr. Shinya Yamanaka. They are among the many Nobel laureates whose important work throughout the...
October 3, 2012 The first Presidential debate was a missed opportunity for the candidates to outline a vision for putting research and innovation to work to improve health and strengthen the economy. Fleeting references to science and research failed to give voters confidence in this regard. We learned some things in this debate, but we are still — many of us literally — dying to know what either candidate will do to assure that research for health will be a priority for this nation. Without medical progress, driven by research and innovation, there will be no chance of controlling health care costs or assuring our nation’s continued leadership in the life sciences. We strongly urge the...
Dear Research Advocate, The first presidential debate gave us little to go on regarding research for health. Americans are dying to know more ’€“ many, quite literally dying ’€“ about what either presidential candidate would do to speed up medical progress in the face of Alzheimer’€™s disease, Parkinson’€™s disease, ALS and the host of other disabling and deadly health threats that breed suffering, compromise independence and drive spiraling health care costs. Add to that the pivotal role medical innovation plays in our economy, and Americans absolutely deserve to know whether candidates will champion or shortchange it. All of us must say to candidates: Tell us what you will do, share your...
Dear Research Advocate, To call attention to the unintended consequences of the sequester, we held a press briefing today in partnership with United for Medical Research. Two Members of Congress who are still in town, Reps. Ed Markey (D-MA) and Brian Bilbray (R-CA), spoke about the high priority the nation must place on NIH and about the usefulness of data from a new national public opinion poll showing that 51% of Americans say that across-the-board cuts are not the right way to reduce the deficit. To see more poll results for use in your advocacy, click here . Other speakers this morning spoke about what’€™s at stake for everyone who cares about the research enterprise: patient hopes for...
Dear Research Advocate, Congress is back in Washington but still in campaign mode, making its decisions with the election very much in mind. A 6-month continuing resolution (C.R.) is expected to pass momentarily. The C.R. would put off appropriations decision-making until the new Congress has gotten under way, flat-funding the government through March of next year at fiscal 2012 levels. The atmosphere of fiscal uncertainty for the agencies that fund research, and everyone seeking that funding, is in fact demoralizing in the extreme. Compounding the problem is that the C.R. does nothing to address the looming problem of sequestration, which is scheduled to take effect on January 2, 2013. The...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter